OR WAIT null SECS
© 2022 MJH Life Sciences and Rheumatology Network. All rights reserved.
© 2022 MJH Life Sciences™ and Rheumatology Network. All rights reserved.
Michael D. Clayman, MD, is chief executive officer and co-founder, Flexion Therapeutics.
Treatment of the osteoarthritis has been at a standstill, with short-term pain management with steroid injections considered standard care. However, a promising new therapeutic approach may help to sustain pain relief over time.